glp 1 agonist microdosing Noom expands its GLP-1 range with 'microdose' package Microdosing GLP-1 Drugs: What To

The lower price point and the approachability of a pill versus a shot opens up the market to casually interested patients, said BMO Capital Markets analyst Evan David Seigerman

cardiovascular death, myocardial infarction, stroke, hospitalization for unstable angina) occurred in 109 participants

As researchers learn more about the biological processes involved in appetite and metabolism, weight management shifts from a matter of willpower to a complex but medically treatable condition

Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist for obesity treatment: A systematic review and meta-analysis of randomized controlled trials

Insulin resistance, visceral adiposity, gut permeability, and metabolic endotoxemia create a baseline inflammatory state that lowers the threshold for autoimmune flares